Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMYD5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SPATA13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GABRA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | STKLD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HOOK1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SCAF8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SP100 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PELI3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TMEM267 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ELL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |